Discovery of mk-8353: an orally bioavailable dual mechanism erk inhibitor for oncology Deposition Author(s): Alhassan, A.B. , Bishop, R. , Boga, S.B. , Buevich, A. , Carr, D. , Cooper, A. , Cox, K. , Dayananth, P. , Deng, Y. , Desai, J. , Doll, R. , Gao, X. , Gudipati, S. , Hesk, D. , Hruza, A.W. , Jin, W. , Kelly, J. , Kirschmeier, P. , Liu, G. , Long, B. , Mei, H. , Muppalla, K. , Nan, Y. , Paliwal, S. , Patel, M. , Samatar, A.A. , Sherborne, B. , Shih, N. , Shipps Jr., G.W. , Sun, R. , Taylor, S.A. , Tsui, H. , Wang, J. , Wang, T. , Windsor, W.T. , Xiao, L. , Yao, X. , Zhang, L. , Zhu, H. , Zhu, L.
Date: 2018-05-06 Method: X-RAY DIFFRACTION Resolution: 1.45 Å Organism(s): Rattus Norvegicus Sequences Data: 6DCG_A